SHZ · Financial Statements

Zhejiang Tianyu Pharmaceutical Co., Ltd. (300702.SZ) Financial Statements

$20.10 SHZ: 300702.SZ Market Cap $7.27B

Full income statement, balance sheet, and cash flow statement for Zhejiang Tianyu Pharmaceutical Co., Ltd. (300702.SZ), plus valuation and return ratios.

Annual financials are not yet available for this stock.

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA15.70
FCF Yield—
Quick Ratio0.54
Interest Coverage—
Return 1Y-20.82%
Return 3Y-9.13%
Return 5Y-45.47%

Zhejiang Tianyu Pharmaceutical Co., Ltd. (300702.SZ) financials — frequently asked questions

What is 300702.SZ EV/EBITDA?

Zhejiang Tianyu Pharmaceutical Co., Ltd.'s enterprise value to EBITDA (EV/EBITDA) ratio is 15.70.

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksAll stock screens
300702.SZ Overview 300702.SZ Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.